High-throughput method characterizes hundreds of previously unknown antibiotic resistance mutations.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39824824.
- Also identified by DOI 10.1038/s41467-025-56050-2 and PMC identifier 11742677.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
A fundamental obstacle to tackling the antimicrobial resistance crisis is identifying mutations that lead to resistance in a given genomic background and environment. We present a high-throughput technique - Quantitative Mutational Scan sequencing (QMS-seq) - that enables quantitative comparison of which genes are under antibiotic selection and captures how genetic background influences resistance evolution. We compare four E. coli strains exposed to ciprofloxacin, cycloserine, or nitrofurantoin and identify 812 resistance mutations, many in genes and regulatory regions not previously associated with resistance. We find that multi-drug and antibiotic-specific resistance are acquired through categorically different types of mutations, and that minor genotypic differences significantly influence evolutionary routes to resistance. By quantifying mutation frequency with single base pair resolution, QMS-seq informs about the underlying mechanisms of resistance and identifies mutational hotspots within genes. Our method provides a way to rapidly screen for resistance mutations while assessing the impact of multiple confounding factors.
Medical subject headings
- Escherichia coli
- Mutation
- Anti-Bacterial Agents
- High-Throughput Nucleotide Sequencing
- Drug Resistance, Bacterial
- Drug Resistance, Multiple, Bacterial